A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment

技术驱动的干预措施可改善认知障碍的早期检测和管理

基本信息

  • 批准号:
    10838956
  • 负责人:
  • 金额:
    $ 23.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-21 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary The prevalence of cognitive impairment (CI) is expected to triple by 2050, contributing to decreased quality of life, increased medical care utilization, and additional burden on an already stressed primary care system. Many clinicians lack confidence to assess, diagnose and manage CI, and more than 50% of patients with CI are undiagnosed. To address these important problems, in phase 1 (R61) of this project, we developed and validated a machine learning model called MC-PLUS using results from brief Mini-Cog screens completed routinely at Annual Medicare Wellness exams and electronic health record (EHR) data to identify patients at elevated risk of a future CI diagnosis. We also developed, validated, and piloted a CI clinical decision support (CI-CDS) system to engage patients and clinicians in conversation about elevated CI risk, and to give clinicians the confidence and tools they need to diagnose and manage CI. Both MC-PLUS and the CI-CDS system were added into an existing web-based CDS platform that has high use rates and high primary care clinician satisfaction and is already seamlessly integrated with the Epic EHR. We are currently beginning phase 2 (R33), a large pragmatic trial with 30 primary care clinics randomized to receive CI-CDS or usual care (UC). We will evaluate the change in CI diagnosis and clinician confidence in diagnosing and managing CI among providers in CI-CDS clinics compared to those in UC clinics. If successful, the CI-CDS system will improve rates of new CI diagnosis and narrow existing sociodemographic disparities for adults with elevated CI risk identified by MC-PLUS at index visits in CI-CDS compared to UC clinics. The CI-CDS system will be available to 2 million patients annually at the study sites with the potential to disseminate more broadly through the existing non-commercialized CDS platform built on Epic EHR. However, the CI-CDS design needs to be updated and modernized from our established legacy Epic EHR pipeline to ensure its robustness, sustainability, interoperability, and scalability for dissemination to the larger community. The proposed grant supplement aims to engage our IT (Information Technology), software engineering and internal Epic EHR IT teams to modernize the CI-CDS architecture to enhance its portability, scalability and impact through the following steps: a) migrating CI-CDS to the OpenShift platform; b) converting its Epic EHR- specific integration to Fast Healthcare Interoperability Resources (FHIR)-based application programming interfaces (APIs); and c) re-architecting its patient data extraction and artificial intelligence (AI) inference pipeline for our MC-PLUS model from batch-based to a real-time model. These activities will facilitate broader impact of the tool by allowing integration into many different EHRs.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Leah R Hanson其他文献

Retracted: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
  • DOI:
    10.1186/1744-8069-8-3
  • 发表时间:
    2012-01-11
  • 期刊:
  • 影响因子:
    2.800
  • 作者:
    Jose A Martinez;Manami Kasamatsu;Alma Rosales-Hernandez;Leah R Hanson;William H Frey;Cory C Toth
  • 通讯作者:
    Cory C Toth
Retraction Note: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
  • DOI:
    10.1186/1744-8069-10-20
  • 发表时间:
    2014-04-02
  • 期刊:
  • 影响因子:
    2.800
  • 作者:
    Jose A Martinez;Manami Kasamatsu;Alma Rosales-Hernandez;Leah R Hanson;William H Frey;Cory C Toth
  • 通讯作者:
    Cory C Toth

Leah R Hanson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Leah R Hanson', 18)}}的其他基金

A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment
技术驱动的干预措施可改善认知障碍的早期检测和管理
  • 批准号:
    10266775
  • 财政年份:
    2020
  • 资助金额:
    $ 23.7万
  • 项目类别:
A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment
技术驱动的干预措施可改善认知障碍的早期检测和管理
  • 批准号:
    10092423
  • 财政年份:
    2020
  • 资助金额:
    $ 23.7万
  • 项目类别:
A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment
技术驱动的干预措施可改善认知障碍的早期检测和管理
  • 批准号:
    10685809
  • 财政年份:
    2020
  • 资助金额:
    $ 23.7万
  • 项目类别:

相似海外基金

Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 23.7万
  • 项目类别:
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 23.7万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 23.7万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 23.7万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 23.7万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 23.7万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 23.7万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 23.7万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 23.7万
  • 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
  • 批准号:
    10806365
  • 财政年份:
    2023
  • 资助金额:
    $ 23.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了